This inventor holds 1 USPTO granted patent. Top assignee: Orchid Chemicals & Pharmaceuticals Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Karnambaram Anandhan: Innovator in Histone Deacetylase Inhibitors
Introduction
Karnambaram Anandhan is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target histone deacetylase (HDAC) activity. His work is crucial in the treatment of various medical conditions, including cancer and psoriasis.
Latest Patents
Anandhan holds a patent for "Histone deacetylase inhibitors - Novel compounds of the general formula (I)." This patent describes compounds that exhibit HDAC inhibiting enzymatic activity, along with their derivatives, analogs, and other forms. The invention also includes a method for treating conditions mediated by HDAC in mammals, which involves administering an effective amount of the novel compounds.
Career Highlights
Karnambaram Anandhan is associated with Orchid Chemicals & Pharmaceuticals Limited, where he applies his expertise in pharmaceutical innovation. His work has contributed to the advancement of treatments for proliferative conditions and other diseases.
Collaborations
Anandhan has collaborated with notable colleagues, including Sridharan Rajagopal and Virendra Kachhadia, to further enhance the research and development of pharmaceutical solutions.
Conclusion
Karnambaram Anandhan's innovative work in histone deacetylase inhibitors showcases his commitment to advancing medical treatments. His contributions are vital in the ongoing fight against serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile